Femasys Inc

Research Femasys Inc (FEMY) on Bullrun: market cap USD 225.86M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerFEMY
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Instruments & Supplies
• CurrencyUSD
• Market capUSD 225.86M
• Financial periodFY2025
• RevenueUSD 2.29M
• Revenue growth40.8%
• Net income-USD 18.63M
• Free cash flow-USD 19.22M
• Gross margin62.0%

Valuation Snapshot

latest market cap is USD 225.86M.

About Femasys Inc

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis;

Frequently asked questions

What is Femasys Inc's market cap?

Femasys Inc's market capitalization is USD 225.86M.

What does Femasys Inc do?

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device;